Secondary Progressive Multiple Sclerosis: New Insights.
Cree BAC, Arnold DL, Chataway J, Chitnis T, Fox RJ, Pozo Ramajo A, Murphy N, Lassmann H.
Neurology. 2021 Aug 24;97(8):378-388. doi: 10.1212/WNL.0000000000012323. Epub 2021 Jun 4.
Progressive Multiple Sclerosis.
Amezcua L.
Continuum (Minneap Minn). 2022 Aug 1;28(4):1083-1103. doi: 10.1212/CON.0000000000001157.
Diagnosis and treatment of progressive multiple sclerosis: A position paper.
Pozzilli C, Pugliatti M, Vermersch P, Grigoriadis N, Alkhawajah M, Airas L, Oreja-Guevara C.
Eur J Neurol. 2023 Jan;30(1):9-21. doi: 10.1111/ene.15593. Epub 2022 Oct 25.
Secondary Progressive Multiple Sclerosis: A Review of Clinical Characteristics, Definition, Prognostic Tools, and Disease-Modifying Therapies.
Ziemssen T, Bhan V, Chataway J, Chitnis T, Campbell Cree BA, Havrdova EK, Kappos L, Labauge P, Miller A, Nakahara J, Oreja-Guevara C, Palace J, Singer B, Trojano M, Patil A, Rauser B, Hach T.
Neurol Neuroimmunol Neuroinflamm. 2022 Nov 22;10(1):e200064. doi: 10.1212/NXI.0000000000200064. Print 2023 Jan.
Progressive multiple sclerosis: pathology and pathogenesis.
Lassmann H, van Horssen J, Mahad D.
Nat Rev Neurol. 2012 Nov 5;8(11):647-56. doi: 10.1038/nrneurol.2012.168. Epub 2012 Sep 25.
Diagnosis and management of secondary-progressive multiple sclerosis: time for change.
Oh J, Alikhani K, Bruno T, Devonshire V, Giacomini PS, Giuliani F, Nakhaipour HR, Schecter R, Larochelle C.
Neurodegener Dis Manag. 2019 Dec;9(6):301-317. doi: 10.2217/nmt-2019-0024. Epub 2019 Nov 26.
Rituximab in secondary progressive multiple sclerosis: a meta-analysis.
Intarakhao P, Laipasu T, Jitprapaikulsan J, Apiraksattayakul N, Kosiyakul P, Siritho S, Prayoonwiwat N, Ongphichetmetha T.
Ann Clin Transl Neurol. 2024 Oct;11(10):2707-2718. doi: 10.1002/acn3.52186. Epub 2024 Aug 26.
Diagnosing 'transition' to secondary progressive multiple sclerosis (SPMS): A step-by-step approach for clinicians.
Hamdy E, Talaat F, Ramadan I, Marouf H, Hamdy MM, Sadallah H, El-Ashmawy GAH, Elsalamawy D, Said SM.
Mult Scler Relat Disord. 2022 Apr;60:103718. doi: 10.1016/j.msard.2022.103718. Epub 2022 Mar 5.
Current challenges in secondary progressive multiple sclerosis: diagnosis, activity detection and treatment.
Brieva L, Calles C, Landete L, Oreja-Guevara C.
Front Immunol. 2025 Mar 21;16:1543649. doi: 10.3389/fimmu.2025.1543649. eCollection 2025.
Pathophysiology, Diagnosis, Treatment and Emerging Neurotherapeutic Targets for Progressive Multiple Sclerosis: The Age of PIRA.
Carlson AK, Fox RJ.
Neurol Clin. 2024 Feb;42(1):39-54. doi: 10.1016/j.ncl.2023.07.002. Epub 2023 Aug 21.
